Social Norms and Priming to Improve Adherence to Antiretroviral Therapy and Retention in Care
- Conditions
- AdherenceHIV Infection
- Interventions
- Behavioral: Intervention
- Registration Number
- NCT02938533
- Lead Sponsor
- University of California, Berkeley
- Brief Summary
Interventions incorporating constructs from behavioral economics and psychology have the potential to enhance HIV 'treatment as prevention' (TasP) strategies. To test this hypothesis, the investigators evaluated a combination intervention to improve antiretroviral therapy (ART) adherence based on the concepts of social norms and priming.
- Detailed Description
The investigators conducted a quasi-experimental pilot study of a combination behavioral intervention based on the concepts of social norms and priming. The intervention included visual feedback about clinic-level retention in care, a self-relevant prime, and useful take-home items with the priming image. The intervention was developed using tools from marketing research and patient-centered design. The hypothesis was that the intervention would improve retention in care and adherence to ART among patients living with HIV infection (PLHIV). The intervention was implemented at two HIV primary clinics in Shinyanga, Tanzania in 2-week intervals for six months. The investigators reviewed medical records of a random sample of exposed and unexposed adult PLHIV to compare retention and the proportion of patients with medication possession ratio (MPR) ≥95% after six months.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 438
- At least 18 years of age
- Living with HIV infection
- Receiving HIV primary care at one of the two study clinics
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Behavioral Intervention Using Social Norms and Priming Intervention Patients in this arm may have been exposed to the behavioral intervention, which included the following components: 1) visual feedback about clinic-level retention in care through an interactive poster; 2) a self-relevant priming image that appeared on all components; and 3) a take-home item (i.e., pillbox or calendar) with the priming image.
- Primary Outcome Measures
Name Time Method Retention in care, defined as an attended visit between 150-210 days after the baseline visit 6 months This measure of retention in care accounts for variability in visit scheduling by individual providers and therefore uses a window period of 150-210 days to determine whether the patient was in care at 6 months
>=95% medication possession ratio (MPR) 6 months MPR is a measure of ART adherence that is correlated with viral suppression
- Secondary Outcome Measures
Name Time Method The proportion of scheduled visits that were completed during the 6-month observation period 6 months Medication possession ratio (MPR), continuous scale 6 months
Trial Locations
- Locations (2)
Bugsi Dispensary
🇹🇿Kahama, Shinyanga, Tanzania
Tinde Health Center
🇹🇿Shinyanga, Tanzania